{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:33:04Z","timestamp":1787776384204,"version":"build-2784847793"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      Vesicoureteric reflux (VUR), recurrent urinary tract infection (RUTI), febrile urinary tract infection (FUTI), renal scarring, and renal damage are intimately related. Key factors of renal damage in VUR are suspected to be RUTI and FUTI. Hence, conventional treatments are targeted toward the prevention of RUTI and FUTI. However, literatures have witnessed that control of infection is not sufficient enough. That means we are missing some hidden, enigmatic, or overlooked factors which are essentially responsible for renal damage. We know RUTI occurs from the stasis of urine in system and stasis might occur from obstruction somewhere in system. Moreover, obstruction builds up back pressure in the bladder and ureters, and ultimately in kidneys; that pressure is independently harmful to renal function. Pressure is further harmful if this joins together with infection. We know that RUTI and FUTI along with pressure in the urinary tract are harmful to renal parenchyma. Nevertheless, search for the nexus of obstruction, pressure, stasis, infection, and damage (OPSID) of renal function is not yet focused on in VUR research. In this retrospective study on\n                      <jats:italic toggle=\"yes\">secondary<\/jats:italic>\n                      VUR, we would like to find the overlooked factors or nexus of OPSID associated with VUR causing renal damage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>\n                      A total of 170 renal units of 135 patients with VUR resulted from the posterior urethral valve and from repaired bladder exstrophy, from March 2005 to April 2019, had adequate data regarding control\/correction of obstruction and urodynamic studies. The mean patient's age was 2.8 years (range 1 day\u201314 years). The diagnosis of VURs was made with postnatal cystogram in patients of the posterior urethral valve and of repaired continent augmented bladder exstrophy. We do cystogram not micturating cystogram following ultrasonography if showing dilated ureter\/s. If we find no residual in ureter\/s after 30 min in cystogram, we label it as \u201crise and fall\u201d VUR (\n                      <jats:italic toggle=\"yes\">raf_<\/jats:italic>\n                      VUR), i.e., without obstruction. On the other hand, if there is post void residual in ureter\/s for more than 30 min, we label it as \u201crise and stasis\u201d VUR (\n                      <jats:italic toggle=\"yes\">ras_<\/jats:italic>\n                      VUR) means combination of VUR with uretero vesical junction obstruction (UVJO). Along with this, all patients were followed up with albumin creatinine ratio, creatinine clearance, USG Renometry, DTPA renal scan, uroflowmetry, and urodynamic study (UDS). Repeat cystoscopy, if necessary, was done following UDS for secondary bladder neck incision (BNI) or for repeat BNI if necessary.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Mean duration of follow-up was 7.2 years (range 3\u201314 years). Out of 170 renal units, 132 renal units had VUR without VUJO, i.e.,\n                      <jats:italic toggle=\"yes\">raf_VUR<\/jats:italic>\n                      and 38 renal units had\n                      <jats:italic toggle=\"yes\">ras_<\/jats:italic>\n                      VUR. All patients of UVJO were relieved either with anticholinergics or with DJ stenting or by re-implantations. Twenty-nine patients out of 135 had high pressure on UDS, and they needed BNI. We were able to prevent upstaging of chronic kidney disease (USCKD) in all 135 patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Our tangible goal of treatment in VUR is the prevention of USCKD. We differentiated\n                      <jats:italic toggle=\"yes\">raf_VUR<\/jats:italic>\n                      from\n                      <jats:italic toggle=\"yes\">ras_VUR<\/jats:italic>\n                      with cystogram. Patients with\n                      <jats:italic toggle=\"yes\">ras_VUR<\/jats:italic>\n                      and patients with\n                      <jats:italic toggle=\"yes\">raf_VUR<\/jats:italic>\n                      with high bladder pressure were actively treated. This particular subset VUR was treated with prophylactic antibiotic and surgical corrections. We prevented renal damage by eliminating obstruction and stasis which helped to prevent RUTI and FUTI. Possibly, similar management might also help to manage \u201cprimary VUR.\u201d Possibly those overlooked factors which are essentially responsible for renal damage are veiled in nexus OPSID of the kidney.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jiaps.jiaps_65_22","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T10:55:00Z","timestamp":1716548100000},"page":"29-34","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Overlooked Factors Causing Renal Damage in Vesicoureteric Reflux!"],"prefix":"10.4103","volume":"28","author":[{"given":"Uday Sankar","family":"Chatterjee","sequence":"first","affiliation":[{"name":"Pediatric Surgery, Park Medical Research and Welfare Society, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashoke Kumar","family":"Basu","sequence":"additional","affiliation":[{"name":"Pediatric Surgery, Park Medical Research and Welfare Society, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Mitra","sequence":"additional","affiliation":[{"name":"Pediatric Surgery, Park Medical Research and Welfare Society, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Basak","sequence":"additional","affiliation":[{"name":"Pediatric Surgery, Park Medical Research and Welfare Society, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"R1-20250528","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0022-5347(17)37555-9","article-title":"Renal scarring following reflux and nonreflux pyelonephritis in children: Evaluation with 99mtechnetium-dimercaptosuccinic acid scintigraphy","volume":"147","author":"Rushton","year":"1992","journal-title":"J Urol"},{"key":"R2-20250528","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/JU.0000000000000292","article-title":"Why does prevention of recurrent urinary tract infection not result in less renal scarring? A deeper dive into the RIVUR trial","volume":"202","author":"Wang","year":"2019","journal-title":"J Urol"},{"key":"R3-20250528","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jpurol.2012.11.019","article-title":"Prevalence and risk factors for renal scars in children with febrile UTI and\/or VUR: A cross-sectional observational study of 565 consecutive patients","volume":"9","author":"Snodgrass","year":"2013","journal-title":"J Pediatr Urol"},{"key":"R5-20250528","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4103\/jiaps.JIAPS_136_19","article-title":"Insight into posterior urethral valve from our experience: Paradigm appended to abate renal failure","volume":"25","author":"Chatterjee","year":"2020","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"R6-20250528","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.4111\/icu.2017.58.S1.S14","article-title":"Critical appraisal of the top-down approach for vesicoureteral reflux","volume":"58","author":"Abdelhalim","year":"2017","journal-title":"Investig Clin Urol"},{"issue":"Suppl 1","key":"R7-20250528","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1464-410X.92.s1.12.x","article-title":"The effect of bladder outlet obstruction on the developing kidney","volume":"92","author":"Aslan","year":"2003","journal-title":"BJU Int"},{"key":"R8-20250528","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.ju.0000129139.10189.3f","article-title":"When can persistent hydroureteronephrosis in posterior urethral valve disease be considered residual stretching?","volume":"172","author":"Jeffrey","year":"2004","journal-title":"J Urol"},{"key":"R9-20250528","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aju.2012.11.006","article-title":"Primary vesico-ureteric reflux: The need for individualised risk stratification","volume":"11","author":"Hidas","year":"2013","journal-title":"Arab J Urol"},{"key":"R10-20250528","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-5347(01)66495-4","article-title":"Transient urodynamic dysfunction of infancy: Relationship to urinary tract infections and vesicoureteral reflux","volume":"155","author":"Chandra","year":"1996","journal-title":"J Urol"},{"key":"R11-20250528","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0022-3476(00)64048-9","article-title":"Urodynamic dysfunction in infants with vesicoureteral reflux","volume":"136","author":"Chandra","year":"2000","journal-title":"J Pediatr"},{"key":"R12-20250528","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.juro.2010.06.132","article-title":"Vesicoureteral reflux and primary bladder neck dysfunction in children: Urodynamic evaluation and randomized, double-blind, clinical trial on effect of \u03b1-blocker therapy","volume":"184","author":"Kajbafzadeh","year":"2010","journal-title":"J Urol"},{"key":"R13-20250528","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.urology.2011.06.057","article-title":"Is there any role for urodynamic study in children with high-grade vesicoureteral reflux?","volume":"79","author":"Karami","year":"2012","journal-title":"Urology"}],"container-title":["Journal of Indian Association of Pediatric Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jiaps.jiaps_65_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:08:07Z","timestamp":1787774887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jiaps.jiaps_65_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jiaps.jiaps_65_22","relation":{},"ISSN":["0971-9261","1998-3891"],"issn-type":[{"value":"0971-9261","type":"print"},{"value":"1998-3891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-05-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}